Skip to Content

Seffalair Spiromax 12.75 micrograms / 100 micrograms inhalation powder

Licence status
Authorised: 26/03/2021
Active substances
SALMETEROL XINAFOATE, Fluticasone propionate
Dosage Form
Inhalation powder
Licence number
EU/1/21/1533/001-002
Licence holder
Teva B.V.

Licence information

ATC code
R03AK06 salmeterol and fluticasone
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
26/03/2021